Workflow
Maysta Chemical(603041)
icon
Search documents
美思德(603041) - 北京植德(上海)律师事务所关于江苏美思德化学股份有限公司2025年第一次临时股东大会的法律意见书
2025-11-14 10:00
北京植德(上海)律师事务所 关于江苏美思德化学股份有限公司 2025 年第一次临时股东大会的 法律意见书 植德沪(会)字[2025]0047 号 二〇二五年十一月 上海市徐汇区虹桥路 183 号徐家汇中心三期 A 座办公楼 27 层(THREE itc) 邮编:200030 27 th Floor Tower A, THREE itc, No.183 Hongqiao Road, Xuhui District, Shanghai 200030 P.R.C 电话(Tel):021-52533500 传真(Fax):021-52533599 www.meritsandtree.com 北京植德(上海)律师事务所 关于江苏美思德化学股份有限公司 2025 年第一次临时股东大会的 法律意见书 植德沪(会)字[2025]0047 号 致:江苏美思德化学股份有限公司(美思德/贵公司) 北京植德(上海)律师事务所(以下简称"本所")接受贵公司的委托,指 派律师出席并见证贵公司 2025 年第一次临时股东大会(以下简称"本次会议")。 本所律师参加本次会议进行见证,并根据《中华人民共和国公司法》(以下 简称"《公司法》")、 ...
美思德(603041) - 2025年第一次临时股东大会决议公告
2025-11-14 10:00
证券代码:603041 证券简称:美思德 公告编号:2025-036 江苏美思德化学股份有限公司 2025年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 本次会议是否有否决议案:无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 98 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数(股) | 93,106,628 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例(%) | 51.3981 | (四) 表决方式是否符合《公司法》及《公司章程》的规定,大会主持情况等。 本次股东大会由公司董事会召集,现场会议由公司董事长孙宇先生主持。会 (一) 股东大会召开的时间:2025 年 11 月 14 日 (二) 股东大会召开的地点:南京经济技术开发区恒泰路 8 号汇智科技园 A3 栋之公司七楼会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况: 议采用现场投票和网络投票相结合的表决方 ...
美思德(603041) - 2025年第一次临时股东大会会议资料
2025-11-06 09:00
江苏美思德化学股份有限公司 2025 年第一次临时股东大会会议资料 江苏美思德化学股份有限公司 2025 年第一次临时股东大会 会议资料 证券代码:603041 江苏·南京 二○二五年十一月 江苏美思德化学股份有限公司 2025 年第一次临时股东大会会议资料 江苏美思德化学股份有限公司 2025 年第一次临时股东大会会议资料目录 | 一、2025 | 年第一次临时股东大会会议须知 2 | | --- | --- | | 二、2025 | 年第一次临时股东大会会议议程 4 | | 三、2025 | 年第一次临时股东大会会议议案 | | 议案 | 1:关于取消监事会并修订《公司章程》的议案 6 | | 议案 | 2:关于制定、修订公司部分管理制度的议案 36 | 1 江苏美思德化学股份有限公司 2025 年第一次临时股东大会会议资料 江苏美思德化学股份有限公司 2025 年第一次临时股东大会会议须知 为维护江苏美思德化学股份有限公司(以下简称"公司")全体股东的合法 权益,确保股东大会的正常秩序和议事效率,保证大会的顺利进行,根据《中华 人民共和国公司法》、《中华人民共和国证券法》等法律法规以及《公司章程》 和《 ...
机构风向标 | 美思德(603041)2025年三季度已披露持仓机构仅6家
Xin Lang Cai Jing· 2025-10-30 01:40
Core Viewpoint - Meiside (603041.SH) reported its Q3 2025 results, highlighting a significant presence of institutional investors holding 46.24% of its total shares, with a slight decrease in institutional ownership compared to the previous quarter [1] Institutional Investors - As of October 29, 2025, six institutional investors disclosed holdings in Meiside A-shares, totaling 84.6945 million shares [1] - The institutional investors include notable entities such as Foshan Shunde Demai Chemical Group Co., Ltd., Zhoushan Shichuang Changrong Equity Investment Co., Ltd., and several mutual funds [1] - The total institutional holding percentage decreased by 0.36 percentage points compared to the previous quarter [1] Public Funds - One public fund, Nuoan Multi-Strategy Mixed Fund, increased its holdings in the current period, with an increase percentage of 0.34% [1] - Three new public funds disclosed their holdings this quarter, including CITIC Prudential Multi-Strategy Mixed (LOF) A, Zhongjia Specialized and New Quantitative Stock Selection Mixed Initiation A, and Morgan Dynamic Multi-Factor Mixed A [1] - Nineteen public funds that were previously disclosed did not report their holdings this quarter, including notable funds like Everbright Prudential Quantitative Stock A and Xingquan CSI 300 Index Enhanced (LOF) A [1]
江苏美思德化学股份有限公司2025年第三季度报告
Core Points - The company held its eighth meeting of the fifth board of directors on October 29, 2025, to discuss various important matters, including the third-quarter report and governance structure changes [9][10][12]. Financial Data - The third-quarter financial report for 2025 was approved, and it is noted that the financial statements are unaudited [3][10]. - The company reported no significant changes in the net profit of merged entities, with both current and previous periods showing a net profit of 0.00 yuan [6][7]. Governance Changes - The company decided to abolish the supervisory board, transferring its responsibilities to the audit committee of the board of directors, in order to optimize the governance structure [16][58]. - Amendments to the company's articles of association were proposed to reflect this change, which will require approval at the upcoming shareholder meeting [58][59]. Management System Updates - The board approved the formulation and revision of several management systems to enhance operational standards, with some requiring shareholder approval to take effect [19][59]. - Specific management systems revised include those related to board meetings, independent directors, and financial management [20][21][22][23][24][25][26][27][28][29]. Upcoming Shareholder Meeting - The company will hold its first extraordinary general meeting of 2025 on November 14, 2025, to discuss the approved proposals and other matters [38][41]. - The meeting will utilize a combination of on-site and online voting methods, with specific details provided for participation [39][40].
江苏美思德化学股份有限公司
Core Points - Jiangsu Meiside Chemical Co., Ltd. has disclosed its major operating data for the third quarter of 2025, in compliance with the Shanghai Stock Exchange's regulations [1][2] - The company plans to hold a performance briefing on November 21, 2025, to discuss its Q3 results and address investor questions [6][7] Group 1: Major Operating Data - The company has reported its production, sales, and revenue figures for its main products, which are based on internal statistics and are unaudited [1][2] - There are no significant events during the reporting period that have impacted the company's operations [2] Group 2: Performance Briefing - The performance briefing will take place on November 21, 2025, from 13:00 to 14:00 at the Shanghai Stock Exchange Roadshow Center [5][7] - Investors can submit questions for the briefing from November 14 to November 20, 2025, through the Roadshow Center's website or via email [8][9] Group 3: Cash Management Announcement - The company has approved an increase in the use of idle funds for cash management, allowing up to RMB 100 million for investment in safe and liquid short-term financial products [12][14] - The total limit for cash management has now increased to RMB 600 million [14][19]
美思德(603041.SH):前三季度净利润4516.7万元,同比下降41.83%
Ge Long Hui A P P· 2025-10-29 15:28
Core Viewpoint - Meiside (603041.SH) reported its Q3 results, showing a revenue increase but a significant decline in net profit [1] Financial Performance - For the first three quarters of 2025, the company achieved total operating revenue of 466 million yuan, representing a year-on-year growth of 4.56% [1] - The net profit attributable to shareholders of the parent company was 45.17 million yuan, reflecting a year-on-year decrease of 41.83% [1] - The basic earnings per share stood at 0.25 yuan [1]
美思德:2025年前三季度净利润约4517万元
Mei Ri Jing Ji Xin Wen· 2025-10-29 10:25
Company Performance - Meiside reported Q3 performance with revenue of approximately 466 million yuan, an increase of 4.56% year-on-year [1] - Net profit attributable to shareholders was approximately 45.17 million yuan, a decrease of 41.83% year-on-year [1] - Basic earnings per share were 0.25 yuan, down 41.86% year-on-year [1] Market Context - As of the report, Meiside's market capitalization stands at 2.3 billion yuan [2] - The A-share market has surpassed 4000 points, indicating a significant market resurgence after a decade of stagnation, with technology leading the market transformation [2]
美思德(603041) - 2025年三季度主要经营数据公告
2025-10-29 10:18
证券代码:603041 证券简称:美思德 公告编号:2025-028 江苏美思德化学股份有限公司 2025 年三季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 江苏美思德化学股份有限公司(以下简称"公司")根据《上海证券交易 所上市公司自律监管指引第 3 号——行业信息披露》及其附件《第十三号—— 化工》、《关于做好主板上市公司 2025 年第三季度报告披露工作的重要提醒》 的要求,现将公司 2025 年三季度主要经营数据(均不含税)披露如下: 注:公司部分产品存在内部自用情况。 主要产品 2025年1-9月产量 (吨) 2025 年 1-9 月销 量(吨) 2025 年 1-9 月营业 收入(万元) 硬泡助剂 16,593.16 15,703.36 35,362.00 软泡助剂 3,258.58 3,314.40 10,036.99 合计 19,851.74 19,017.76 45,398.99 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 2025 | 年 | 1-9 | 月平均销 | ...
美思德(603041) - 关于公司及子公司增加使用自有闲置资金进行现金管理额度的公告
2025-10-29 10:18
证券代码:603041 证券简称:美思德 公告编号:2025-032 江苏美思德化学股份有限公司 基本情况 | 投资金额 | 江苏美思德化学股份有限公司(以下简称"公司")及子公司拟 | | --- | --- | | | 增加使用额度不超过人民币 1 亿元(含本数)的自有闲置资金进 | | | 行现金管理。本次增加后,公司及子公司使用闲置自有资金进行 | | | 现金管理的总额度不超过人民币 6 亿元(含本数)。 | | 投资种类 | 公司及其子公司拟使用自有闲置资金用于投资购买安全性高、流 | | | 动性好的短期稳健型理财产品(包括但不限于银行固定收益型或 | | | 浮动收益型的理财产品、结构性存款及证券公司收益凭证等)。 | | 资金来源 | 自有资金 | 履行的审议程序 公司于 2025年10月29日召开的第五届董事会第八次会议审议通过了《关 于公司及子公司增加使用自有闲置资金进行现金管理额度的议案》,同意公司 及子公司增加使用额度不超过人民币 1 亿元(含本数)的自有闲置资金进行 现金管理,购买安全性高、流动性好的短期理财产品,使用期限自公司本次 董事会审议通过之日起 12 个月。在上述额度及使 ...